Rab13 Sustains Breast Cancer Stem Cells by Supporting Tumor-Stroma Cross-talk.
Hui WangHaibo XuWei ChenMei ChengLi ZouQin YangChi Bun ChanHao ZhuCeshi ChenJianyun NieBaowei JiaoPublished in: Cancer research (2022)
Targeting Rab13 perturbs formation of the breast cancer stem cell niche by inhibiting cross-talk between cancer cells and the tumor microenvironment, providing a therapeutic opportunity for niche-targeted breast cancer treatment.